Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMNN
IMNN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMNN News
IMUNON Announces Transition in Financial Leadership
Jul 01 2026
seekingalpha
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Virtual Investor Conferences Forum Highlights
Jun 26 2026
Globenewswire
Agenda Announced for Life Sciences Virtual Investor Forum
Jun 23 2026
Globenewswire
IMUNON CEO to Present at Life Sciences Investor Forum
Jun 22 2026
Newsfilter
IMUNON Secures $10 Million Financing for Clinical Trials
Jun 05 2026
NASDAQ.COM
IMUNON Secures $10 Million Financing Agreement
Jun 04 2026
seekingalpha
Imunon IMNN Q4 2025 Earnings Transcript
Jun 01 2026
NASDAQ.COM
IMUNON (IMNN) Q1 2026 Earnings Call Insights
May 12 2026
seekingalpha
Imunon Q1 Earnings Beat Expectations
May 12 2026
seekingalpha
IMUNON to Host Q1 2026 Financial Results Conference Call
May 05 2026
Newsfilter
Imunon Reports Improved Survival Rates and Extended Operating Runway
Mar 31 2026
Yahoo Finance
Imunon Q4 2025 Earnings Call Highlights
Mar 31 2026
seekingalpha
Imunon Reports FY Losses, EPS at -$6.83
Mar 31 2026
seekingalpha
Imunon Scheduled to Announce Q4 Earnings on March 30
Mar 30 2026
seekingalpha
Biotech Landscape Update: Regulatory Approvals and Mergers
Mar 27 2026
NASDAQ.COM
Show More News